Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33433
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSOUSA, L. F. A. de
dc.contributor.authorPAUPITZ, J. A.
dc.contributor.authorAIKAWA, N. E.
dc.contributor.authorTAKAYAMA, L.
dc.contributor.authorCAPARBO, V. F.
dc.contributor.authorPEREIRA, R. M. R.
dc.date.accessioned2019-09-23T14:15:41Z-
dc.date.available2019-09-23T14:15:41Z-
dc.date.issued2019
dc.identifier.citationLUPUS, v.28, n.10, p.1224-1232, 2019
dc.identifier.issn0961-2033
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33433-
dc.description.abstractObjective Juvenile-onset systemic lupus erythematosus (JoSLE) is associated with low bone mass for age and fractures; nevertheless, risk factors for bone impairment are poorly understood. The aim of this study was to evaluate risk factors for bone mass loss in JoSLE patients. Methods Forty-nine female JoSLE patients were evaluated at baseline and after a 3.5-year follow-up regarding clinical, laboratory (including bone turnover markers), areal bone mineral density (aBMD) and bone microarchitecture parameters using high-resolution peripheral quantitative computed tomography (HR-pQCT). Based on the difference between final and baseline aBMD value, the patients were divided into three groups: aBMD gain (BG), aBMD loss (BL) and aBMD no change (NC). Results The mean patient age was 18.7 +/- 3.3 years. Sixty-one percent of patients presented with aBMD gain, 18.4% aBMD loss, and 20.4% remained stable during this follow-up period. Comparing the BL with the BG group, there was a higher frequency of alcohol consumption (p = 0.009), a higher frequency of inadequate calcium intake (p = 0.047) and lower levels of baseline procollagen type 1 amino-terminal propeptide (P1NP) (p = 0.036) in the BL group. Moreover, worsening of HR-pQCT parameters trabecular volumetric density (p = 0.003) and cortical thickness (p = 0.009) was observed in the BL group. In addition, a higher frequency of renal activity was observed comparing the BL + NC with the BG group (p = 0.036). Conclusions This is the first longitudinal study that has analyzed the risk factors of bone loss in JoSLE patients. The authors emphasize the importance of evaluating lifestyle habits and renal disease activity in these young women. Furthermore, this study suggests that trabecular and cortical compartments deteriorated, and low levels of P1NP may be a predictor of bone impairment in JoSLE.eng
dc.description.sponsorshipConselho Nacional de Ciencia e Tecnologia [301805/2013-0]
dc.description.sponsorshipFederico Foundation
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS LTDeng
dc.relation.ispartofLupus
dc.rightsrestrictedAccesseng
dc.subjectMusculoskeletaleng
dc.subjectrenal lupuseng
dc.subjectsystemic lupus erythematosuseng
dc.subject.othervertebral fracture assessmenteng
dc.subject.otherx-ray absorptiometryeng
dc.subject.othermineral densityeng
dc.subject.othervitamin-deng
dc.subject.othermicroarchitectureeng
dc.subject.otherosteoporosiseng
dc.subject.otheralcoholeng
dc.subject.othercalciumeng
dc.subject.otherdiseaseeng
dc.subject.otherdeteriorationeng
dc.titleRisk factors for bone loss in juvenile-onset systemic lupus erythematosus: a prospective studyeng
dc.typearticleeng
dc.rights.holderCopyright SAGE PUBLICATIONS LTDeng
dc.identifier.doi10.1177/0961203319869467
dc.identifier.pmid31409184
dc.subject.wosRheumatologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.description.articlenumberUNSP 0961203319869467
hcfmusp.description.beginpage1224
hcfmusp.description.endpage1232
hcfmusp.description.issue10
hcfmusp.description.volume28
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000483295100001
hcfmusp.origem.id2-s2.0-85071507671
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceBerg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012eng
hcfmusp.relation.referenceBrandi ML, 2009, RHEUMATOLOGY, V48, pIV3, DOI 10.1093/rheumatology/kep273eng
hcfmusp.relation.referenceCarbonare LD, 2004, J ENDOCRINOL INVEST, V27, P99, DOI 10.1007/BF03350919eng
hcfmusp.relation.referenceCasella CB, 2012, LUPUS, V21, P1335, DOI 10.1177/0961203312454929eng
hcfmusp.relation.referenceFarias Júnior José Cazuza de, 2012, Rev. bras. epidemiol., V15, P198, DOI 10.1590/S1415-790X2012000100018eng
hcfmusp.relation.referenceDomiciano DS, 2013, ARTHRIT CARE RES, V65, P809, DOI 10.1002/acr.21905eng
hcfmusp.relation.referenceDUKE PM, 1980, PEDIATRICS, V66, P918eng
hcfmusp.relation.referenceEl Maghraoui A, 2006, J CLIN DENSITOM, V9, P281, DOI 10.1016/j.jocd.2006.03.014eng
hcfmusp.relation.referenceFlynn A, 2003, P NUTR SOC, V62, P851, DOI 10.1079/PNS2003301eng
hcfmusp.relation.referenceFuller H, 2015, REV BRAS REUMATOL, V55, P352, DOI [10.1016/j.rbr.2014.07.010, 10.1016/j.rbre.2014.07.010]eng
hcfmusp.relation.referenceGarcia-Valdecasas-Campelo E, 2006, ALCOHOL ALCOHOLISM, V41, P261, DOI 10.1093/alcalc/agl004eng
hcfmusp.relation.referenceGENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915eng
hcfmusp.relation.referenceGladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303eng
hcfmusp.relation.referenceGraves DT, 1999, FRONT BIOSCI, V4, P571eng
hcfmusp.relation.referenceHaskelberg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038377eng
hcfmusp.relation.referenceHlaing TT, 2014, ANN CLIN BIOCHEM, V51, P189, DOI 10.1177/0004563213515190eng
hcfmusp.relation.referenceIbanez D, 2005, J RHEUMATOL, V32, P824eng
hcfmusp.relation.referenceLee C, 2005, RHEUM DIS CLIN N AM, V31, P363, DOI 10.1016/j.rdc.2005.01.004eng
hcfmusp.relation.referenceLeslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-Xeng
hcfmusp.relation.referenceLewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106eng
hcfmusp.relation.referenceLilleby V, 2005, ARTHRITIS RHEUM, V52, P2051, DOI 10.1002/art.21115eng
hcfmusp.relation.referenceLim LSH, 2012, ANN RHEUM DIS, V71, P1686, DOI 10.1136/annrheumdis-2011-200805eng
hcfmusp.relation.referenceLima GL, 2018, OSTEOPOROSIS INT, V29, P587, DOI 10.1007/s00198-017-4316-5eng
hcfmusp.relation.referenceLucas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046940eng
hcfmusp.relation.referenceMikosch P, 2014, WIEN MED WOCHENSCHR, V164, P15, DOI 10.1007/s10354-013-0258-5eng
hcfmusp.relation.referenceNIEVES JW, 1995, AM J EPIDEMIOL, V141, P342, DOI 10.1093/aje/141.4.342eng
hcfmusp.relation.referencePaupitz JA, 2016, OSTEOPOROSIS INT, V27, P1839, DOI 10.1007/s00198-015-3461-yeng
hcfmusp.relation.referencePetri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473eng
hcfmusp.relation.referenceResende AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106728eng
hcfmusp.relation.referencePereira RMR, 2010, CLINICS, V65, P1197, DOI 10.1590/S1807-59322010001100024eng
hcfmusp.relation.referenceSeguro LPC, 2015, OSTEOPOROSIS INT, V26, P459, DOI 10.1007/s00198-014-2860-9eng
hcfmusp.relation.referenceSuh KT, 2005, CLIN ORTHOP RELAT R, P220, DOI 10.1097/01.blo.0000150568.16133.3ceng
hcfmusp.relation.referenceTang XL, 2013, LUPUS, V22, P1162, DOI 10.1177/0961203313498802eng
hcfmusp.relation.referenceTang XL, 2013, OSTEOPOROSIS INT, V24, P1817, DOI 10.1007/s00198-012-2177-5eng
hcfmusp.relation.referenceTang XL, 2012, J RHEUMATOL, V39, P1955, DOI 10.3899/jrheum.120213eng
hcfmusp.relation.referenceTeichmann J, 1999, RHEUMATOL INT, V18, P137, DOI 10.1007/s002960050072eng
hcfmusp.relation.referenceVALIMAKI MJ, 1994, BMJ-BRIT MED J, V309, P230, DOI 10.1136/bmj.309.6949.230eng
hcfmusp.relation.referenceVasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1eng
hcfmusp.relation.referenceWang YS, 2003, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000063602.67412.83eng
hcfmusp.relation.referenceWise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403eng
hcfmusp.relation.referenceWosje KS, 2000, NUTR REV, V58, P253eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1477-0962
hcfmusp.citation.scopus2-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia


Files in This Item:
File Description SizeFormat 
art_SOUSA_Risk_factors_for_bone_loss_in_juvenileonset_systemic_2019.PDF
  Restricted Access
publishedVersion (English)106.53 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.